UAE – Medical care giant Al Dhafra Hospitals has set up specialized clinics at its two primary health facilities in Abu Dhabi that will provide integrated mental health services and…
Read MoreDay: 23 January 2023
Dubai launches Aeon Clinic at its new ultra-luxury resort Atlantis The Royal
UAE – Major healthcare win for the United Arab Emirates (UAE) as Dubai has unveiled the AEON Clinic situated its latest luxury resort, Atlantis The Royal, designed to cater to…
Read MoreCentral Public Health Laboratory attains WHO’s accreditation status
NIGERIA – Central Public Health Laboratory (CPHL) has attained a World Health Organization (WHO) full laboratory accreditation status in respect of its contribution to the fight against measles and rubella…
Read MoreGE HealthCare makes first acquisition as an independent company
USA —GE HealthCare has announced the acquisition of IMACTIS, a French developer of computed tomography (CT) interventional guidance technology. The acquisition is the first for the newly independent company, a…
Read MoreMinistry of Health conducts polio vaccination in districts affected by Ebola outbreak
UGANDA – The Ministry of Health (MOH) has commenced a 10-day door-to-door polio vaccination drive in districts that recorded cases of Ebola virus disease in the latest outbreak. The exercise,…
Read MoreNABH joins forces with HSSC to upskill healthcare workforce in India
INDIA – The National Accreditation Board for Hospitals & Healthcare Providers (NABH) has signed a collaboration agreement with the Healthcare Sector Skill Council (HSSC) for the recognition and skilling initiatives…
Read MoreGlenmark unveils fixed-dose combination drug for cancer patients in India
INDIA – Glenmark Pharmaceuticals Limited (Glenmark) has introduced its unique I.V. injection formulation, AKYNZEO® I.V., for cancer patients undergoing chemotherapy in India. Chemotherapy is the most common form of cancer…
Read MoreDr. Reddy’s completes drug studies of its rituximab biosimilar
INDIA – Dr. Reddy’s Laboratories has reached a key milestone on the path to commercialization of its rituximab biosimilar, DRL_RI, as the drug major successfully completed the full set of…
Read More